Atlas Trials

Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age

Clinical trial NCT02075515 · COMPLETED

Trial details

NCT number
NCT02075515
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Herpes ZosterHerpes Zoster Vaccine
Start date
2014-08-13
Primary completion
2015-04-29
Enrollment
651

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.